Therapeutic targeting of the DNA mismatch repair pathway

Area of Science:

• Molecular Biology
• Genetics
• Cancer Research

Background:

• The mismatch repair (MMR) pathway is crucial for DNA stability, correcting errors during replication and repairing DNA damage.
• Defects in MMR genes (MSH2, MLH1, PMS2, MSH6) are linked to hereditary nonpolyposis colon cancer, also known as Lynch syndrome.
• Emerging research indicates noncanonical functions for MMR genes beyond DNA repair.

Purpose of the Study:

• To review the canonical functions of the MMR pathway.
• To explore the noncanonical roles of MMR genes.
• To highlight the therapeutic potential of targeting MMR defects in cancer.

Main Methods:

• Literature review of canonical MMR pathway functions.
• Analysis of emerging evidence for noncanonical MMR gene roles.
• Discussion of therapeutic strategies exploiting MMR deficiency.

Main Results:

• The MMR pathway's established role in DNA mismatch correction.
• Growing evidence for novel, non-DNA repair functions of MMR genes.
• Identification of synthetic lethality approaches for MMR-deficient cancers.

Conclusions:

• MMR pathway defects are key in Lynch syndrome and other cancers.
• Noncanonical MMR gene functions warrant further investigation.
• Exploiting MMR deficiency presents a promising avenue for novel cancer therapeutics.